Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Bolt Biotherapeutics stock

Learn how to easily invest in Bolt Biotherapeutics stock.

Bolt Biotherapeutics, a San Francisco-based company that develops immuno-oncology therapeutics, completed an upsized $220 million IPO, selling 11.5 million shares $20 each.

The stock opened at $26.10 on Friday and jumped more than 25% shortly after it opened for trading.

How to buy Bolt Biotherapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BOLT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Bolt Biotherapeutics stock price (NASDAQ: BOLT)

Use our graph to track the performance of BOLT stocks over time.

Bolt Biotherapeutics shares at a glance

Information last updated 2023-02-01.
Latest market close$1.52
52-week range$1.18 - $3.64
50-day moving average $1.39
200-day moving average $1.72
Wall St. target price$5.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.64

Buy Bolt Biotherapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Bolt Biotherapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bolt Biotherapeutics price performance over time

Historical closes compared with the close of $1.515 from 2023-02-06

1 week (2023-02-01) 3.06%
1 month (2023-01-06) 7.45%
3 months (2022-11-08) 17.44%
6 months (2022-08-08) -34.98%
1 year (2022-02-04) -55.83%
2 years (2021-02-08) -95.35%
3 years (2020-02-04) N/A
5 years (2018-02-04) N/A

Bolt Biotherapeutics financials

Revenue TTM $4.8 million
Gross profit TTM $-74,395,000
Return on assets TTM -20.8%
Return on equity TTM -41.12%
Profit margin 0%
Book value $5.00
Market capitalisation $55.4 million

TTM: trailing 12 months

Bolt Biotherapeutics share dividends

We're not expecting Bolt Biotherapeutics to pay a dividend over the next 12 months.

Bolt Biotherapeutics overview

Bolt Biotherapeutics, Inc. , a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015.

Frequently asked questions

What percentage of Bolt Biotherapeutics is owned by insiders or institutions?
Currently 6.55% of Bolt Biotherapeutics shares are held by insiders and 58.115% by institutions.
How many people work for Bolt Biotherapeutics?
Latest data suggests 91 work at Bolt Biotherapeutics.
When does the fiscal year end for Bolt Biotherapeutics?
Bolt Biotherapeutics's fiscal year ends in December.
Where is Bolt Biotherapeutics based?
Bolt Biotherapeutics's address is: 900 Chesapeake Drive, Redwood City, CA, United States, 94063
What is Bolt Biotherapeutics's ISIN number?
Bolt Biotherapeutics's international securities identification number is: US0977021049

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site